BSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
NSE Live
Sep 30, 15:31Prev. Close
113.75
Open Price
108.10
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
Profit & Loss account of Sotac Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
INCOME | ||||||
Revenue From Operations [Gross] | 62.38 | 67.11 | 57.98 | 73.15 | 43.44 | |
Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Revenue From Operations [Net] | 62.38 | 67.11 | 57.98 | 73.15 | 43.44 | |
Total Operating Revenues | 62.38 | 67.11 | 57.98 | 73.15 | 43.44 | |
Other Income | 2.38 | 1.32 | 0.24 | 0.22 | 0.08 | |
Total Revenue | 64.76 | 68.42 | 58.23 | 73.37 | 43.52 | |
EXPENSES | ||||||
Cost Of Materials Consumed | 39.43 | 42.11 | 42.72 | 56.16 | 34.34 | |
Purchase Of Stock-In Trade | 1.33 | 2.62 | 0.53 | 0.27 | 0.23 | |
Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 3.84 | 1.99 | |
Changes In Inventories Of FG,WIP And Stock-In Trade | 3.16 | 0.48 | -3.18 | -0.45 | -0.50 | |
Employee Benefit Expenses | 1.77 | 2.66 | 2.93 | 2.98 | 2.55 | |
Finance Costs | 1.17 | 1.01 | 0.86 | 0.53 | 0.56 | |
Depreciation And Amortisation Expenses | 2.47 | 2.51 | 1.63 | 1.13 | 1.12 | |
Other Expenses | 9.01 | 9.05 | 6.78 | 4.22 | 2.02 | |
Total Expenses | 58.34 | 60.43 | 52.26 | 68.68 | 42.31 | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 6.41 | 7.99 | 5.96 | 4.69 | 1.21 | |
Exceptional Items | 0.00 | -0.23 | 0.00 | 0.00 | 0.00 | |
Profit/Loss Before Tax | 6.41 | 7.76 | 5.96 | 4.69 | 1.21 | |
Tax Expenses-Continued Operations | ||||||
Current Tax | 1.64 | 2.13 | 1.68 | 1.86 | 0.42 | |
Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax | 0.00 | -0.08 | 0.00 | 0.00 | 0.00 | |
Tax For Earlier Years | 0.00 | -0.04 | 0.00 | 0.00 | 0.00 | |
Total Tax Expenses | 1.64 | 2.01 | 1.47 | 1.82 | 0.34 | |
Profit/Loss After Tax And Before ExtraOrdinary Items | 4.77 | 5.75 | 4.50 | 2.88 | 0.86 | |
Profit/Loss From Continuing Operations | 4.77 | 5.75 | 4.50 | 2.88 | 0.86 | |
Profit/Loss For The Period | 4.77 | 5.75 | 4.50 | 2.88 | 0.86 | |
OTHER ADDITIONAL INFORMATION | ||||||
EARNINGS PER SHARE | ||||||
Basic EPS (Rs.) | 4.32 | 5.24 | 5.58 | 12.51 | 3.75 | |
Diluted EPS (Rs.) | 4.32 | 5.24 | 5.58 | 12.51 | 3.75 | |
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
Equity Share Dividend | 0.00 | 0.00 | 0.00 | 0.46 | 0.00 | |
Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Equity Dividend Rate (%) | 1.00 | 0.00 | 0.00 | 20.00 | 0.00 |
30.10.2024
Sotac Pharma Consolidated September 2024 Net Sales at Rs 27.35 crore, up 2.52% Y-o-Y
27.08.2024
Sotac Pharma Consolidated June 2024 Net Sales at Rs 25.25 crore, up 1.13% Y-o-Y
19.08.2024
Sotac Pharma Standalone June 2024 Net Sales at Rs 13.01 crore, down 31.18% Y-o-Y
18.06.2024
Sotac Pharma Consolidated March 2024 Net Sales at Rs 26.45 crore, up 46.24% Y-o-Y
30.10.2024
Sotac Pharma Consolidated September 2024 Net Sales at Rs 27.35 crore, up 2.52% Y-o-Y
27.08.2024
Sotac Pharma Consolidated June 2024 Net Sales at Rs 25.25 crore, up 1.13% Y-o-Y
19.08.2024
Sotac Pharma Standalone June 2024 Net Sales at Rs 13.01 crore, down 31.18% Y-o-Y
18.06.2024
Sotac Pharma Consolidated March 2024 Net Sales at Rs 26.45 crore, up 46.24% Y-o-Y